Amid incidents of toxic cough syrups, the organization has called on countries and regulators to strengthen action against the threat of substandard and falsified medical products.
Invida has acquired a stake in Indonesia-based MUGI, giving it the local manufacturing presence needed to offer partners access to “a vast untapped market”.
in-PharmaTechnologist.com's periodic round-up of developments in
the pharmaceutical manufacturing space includes the expansion plans
of two Malaysian companies and lay-offs in Ireland.